Antibiotic-resistant bacteria not only endanger people, but also put pressure on the health care system: they could will generate up to $ 3.5 billion in annual spending by 2050 in every OECD country, according to the report, which will be published on Wednesday, November 7th.
"These bacteria are more expensive than flu, AIDS, and tuberculosis, and they will pay even more if states do not work to solve this problem," said AFP Public Health Officer Michele Cechini. OECD (Organization for Economic Co-operation and Development).
According to him, countries already use an average of 10% of their health profiles to treat antibiotic-resistant bacteria.
According to the forecasts of the 36 OECD countries, resistant bacteria could kill 2.4 million people in Europe, North America and Australia by 2050.
A separate study was published on Monday in The Lancet's Communicable Diseases 33,000 deaths associated with these bacteria in 2015 In the European Union.
However, we could fight them by "simple measures" at a reasonable cost, according to the OECD: "encourage better hygiene" (by encouraging, for example, hand washing), "stop antibiotic overexposure" or further generalize rapid diagnostic tests to determine if infection is a virus (where antibiotics are useless) bacteria.
According to the OECD, these measures would cost only $ 2 per person per year and prevents three quarters of deaths.
"Investments in major public health programs, which include some of these measures, can be eliminated for one year and will save $ 4.8 billion a year," OECD says.
The health authorities, who are commencing with the World Health Organization (WHO), will report on a regular basis the risk of excessive consumption of antibiotics, which makes it resistant to substantial bacteria. Small children and the elderly are particularly at risk.
"In Brazil, Indonesia and Russia, 40-60% of the infections are already resistant, compared to an average of 17% in OECD countries, "said the latter.
Still worrying, "the resistance of antibiotics against the second and third lines is expected to be 70 percent higher in 2030 than in 2005". These antibiotics are the ones to be used as a last resort when there is no other solution.